Stock Ratings / Health Care / SENS / forecast

RCEL (44) ANGO (50) DCTH (57) SGHT (38) ⌘ Pro Terminal →

Senseonics Holdings Inc. (SENS) 12-Month Stock Forecast & Price Target Cone

$9.75 +4.39% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $9.81

Senseonics Holdings Inc. (SENS) carries a Roarable Rating of D- (Sell) with 38/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (38/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $515.5M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $9.81 (+0.60%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (38/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.8% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SENS)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (38/100 Composite)

🔍 WHY SENS SCORES 38/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+12/20 pts (32% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+9/20 pts (24% of score)

FRED Regime × Technicals: 85% of 52W Range • RSI-14 at 58 (BULLISH MOMENTUM)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$8.98-13.5% Next Q

Q2 (-2Q)

Grade E$7.77-3.3% Next Q

Q3 (-1Q)

Grade E$7.51+29.8% Next Q

Current

Grade D-$9.75-7.8% Hist 90D α

Trajectory: E (30) → D- (38)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a SENS Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While SENS currently carries a cautious 38/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($9.19) and Max Pain ($10.24) forces dealer call-delta covering toward $11.17.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $SENS• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “SENS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 38%NO 62%Trade / Inspect Odds →

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your SENS Position Size: $10,000

Shares at $9.75: 1025.6 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $6.92

$7,097

$-2,903 (-29.0%)

12M Consensus BaseTarget $8.87

$9,097

$-903 (-9.0%)

12M Bull Case BreakoutTarget $11.17

$11,456

+$1,456 (+14.6%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (35 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 9

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$9	74%	A
Goldman SachsSector Coverage Lead	UNDERPERFORM	$10	69%	B
JP MorganUS Large-Cap Research	SELL	$8	58%	C

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SENS)

✓Walkthrough of SENS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

SENS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +47.50%📐 HORIZONTAL RANGE

2026-10-30O $9.45H $9.75L $9.07C $9.75VOL 988.6K

RES: $11.19SUP: $4.79SMA50: $9.19SMA200: $7.20

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

SENS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 SENS Butterfly Map → + Track SENS →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +56.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on SENS today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for SENS. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for SENS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SENS)

Health Care Rank #707 of 1016 ⚔️ RCEL vs SENS Full Matrix →

1. Head-to-Head Health Care Peer Comparison (SENS vs. RCEL, ANGO, DCTH, SGHT)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Senseonics Holdings Inc. (SENS) ranks #707 by composite RQD confidence (38/100, grade D-) and #444 by equity capitalization ($515.5M). Within this direct 5-issuer industry benchmark cohort, SENS leads on earnings valuation at N/A trailing P/E, while DCTH leads on capital efficiency and profitability with 0.8% ROIC and 86.2% gross margin. DCTH currently holds the highest overall quantitative score in the immediate peer group at 57/100 (D+) compared with SENS at 38/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
SENS ACTIVE Senseonics Holdings Inc.	D-	38/100	—	44.7%	-35.0%	+4.39%	$515.5M	Benchmark Subject
RCEL Avita Medical Inc.	D	44/100	—	82.1%	-35.0%	+1.27%	$516.8M	/rcel-vs-sens →
ANGO AngioDynamics Inc.	D	50/100	—	54.6%	-23.4%	+1.81%	$519.4M	/ango-vs-sens →
DCTH Delcath Systems Inc.	D+	57/100	—	86.2%	0.8%	-1.48%	$508.0M	/dcth-vs-sens →
SGHT Sight Sciences Inc.	D-	38/100	—	86.2%	-35.0%	+3.57%	$527.2M	/sght-vs-sens →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001616543

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Senseonics Holdings Inc. (SENS) reported GAAP revenue of $35.3M (+56.9% vs. FY2024 revenue of $22.5M , and +57.5% cumulative change since FY2023) , GAAP net income of -$69.1M, operating cash flow of -$59.1M, and free cash flow of -$59.1M (+2.2% YoY). On the balance sheet, SENS closed FY2025 with $126.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$35.3M	-$69.1M	-$59.1M	-$59.1M	$126.3M	—
FY2024 (FY)	2024-12-31	$22.5M	-$78.6M	-$60.5M	-$60.5M	$100.4M	—
FY2023 (FY)	2023-12-31	$22.4M	-$60.4M	-$70.2M	-$70.2M	—	—

3. SENS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is SENS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Senseonics Holdings Inc. (NASDAQ: SENS) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $9.75 (+4.39% 1D, market cap $515.5M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, SENS ranks #707 in composite RQD confidence.

How does SENS compare to RCEL and ANGO in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), SENS carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of 44.7%, and ROIC of -35.0%. By comparison, RCEL (Avita Medical Inc.) holds a D grade (44/100 RQD, P/E N/A, ROIC -35.0%, cap $516.8M) and ANGO (AngioDynamics Inc.) posts a D grade (50/100 RQD, P/E N/A, ROIC -23.4%, cap $519.4M). Among the 5-stock peer group, SENS leads on earnings multiple (N/A) while DCTH leads on capital efficiency (0.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for SENS?

Per SENS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001616543), Senseonics Holdings Inc. generated $35.3M in revenue (+56.9% YoY), -$69.1M in net income, and -$59.1M in free cash flow against $126.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is SENS trading relative to its 50-day, 200-day, and 52-week technical levels?

SENS last traded at $9.75 (+4.39% on volume of 522,711 shares), positioning the stock +6.09% above its 50-day simple moving average ($9.19) and +35.42% above its 200-day simple moving average ($7.20). Across its 52-week range of $4.79 to $10.64, SENS sits at the 84.8% percentile with a 14-day RSI of 58.0 (BULLISH MOMENTUM) and an implied next-earnings move of ±12.5% ($8.53 to $10.97).

SENS Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is SENS's 12-month stock price target?

Senseonics Holdings Inc. (SENS) carries a 12-month consensus base price target of $8.87 (-9% from $9.75), with a bull-case target of $11.17 and a bear-case floor of $6.92.

Is SENS stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates SENS D- (Sell — SELL) with an RQD Confidence score of 38/100.

Direct Sub-Reports: SENS RQD Cockpit SENS 12M Forecast SENS Earnings & Move SENS Dividends & DRIP SENS Insiders & 13F SENS Whale Options SENS Profit Sankey SENS News & Why